CO2020005768A2 - Phytoconcentrated composition and its uses - Google Patents
Phytoconcentrated composition and its usesInfo
- Publication number
- CO2020005768A2 CO2020005768A2 CONC2020/0005768A CO2020005768A CO2020005768A2 CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2 CO 2020005768 A CO2020005768 A CO 2020005768A CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2
- Authority
- CO
- Colombia
- Prior art keywords
- composition
- phytoconcentrated
- sedative
- antidepressant
- calming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composición sólida de tipo confitería o de tipo farmacéutica, por ejemplo, bajo forma de pastillas, cápsulas, gránulos o tabletas, que contiene aceite esencial de Cannabis y un soporte a base de azúcar. Semejantes preparaciones brindan a su consumidor una sensación de bienestar que proviene de sus propiedades relajantes, calmantes, sedativas, antiinflamatorias, antidepresivas y analgésicas.Solid composition of the confectionery or pharmaceutical type, for example, in the form of pills, capsules, granules or tablets, containing Cannabis essential oil and a sugar-based support. Such preparations provide its consumer with a feeling of well-being that comes from its relaxing, calming, sedative, anti-inflammatory, antidepressant and analgesic properties.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1759583 | 2017-10-12 | ||
PCT/FR2018/000233 WO2019073127A2 (en) | 2017-10-12 | 2018-10-08 | Phyto-concentrated composition and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2020005768A2 true CO2020005768A2 (en) | 2020-07-31 |
Family
ID=65818034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2020/0005768A CO2020005768A2 (en) | 2017-10-12 | 2020-05-12 | Phytoconcentrated composition and its uses |
Country Status (2)
Country | Link |
---|---|
CO (1) | CO2020005768A2 (en) |
WO (1) | WO2019073127A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230166154A (en) * | 2019-07-29 | 2023-12-06 | 브라이트씨드, 인크. | Method for improving digestive health |
EP4098254A1 (en) * | 2021-06-04 | 2022-12-07 | Assistance Publique, Hopitaux De Paris | Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695661A5 (en) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmaceutical composition. |
FR2973706B1 (en) | 2011-04-06 | 2016-05-20 | Guyen Gerard Duc N | ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT |
CN103082275A (en) * | 2011-10-28 | 2013-05-08 | 冯松平 | Special female beverage effervescent tablets |
CA2928834A1 (en) | 2013-06-13 | 2014-12-18 | Cannabis Science International Holding B.V. | Composition for the treatment of neurobehavioral disorders |
-
2018
- 2018-10-08 WO PCT/FR2018/000233 patent/WO2019073127A2/en active Application Filing
-
2020
- 2020-05-12 CO CONC2020/0005768A patent/CO2020005768A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2019073127A3 (en) | 2019-08-22 |
WO2019073127A2 (en) | 2019-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2017005426A (en) | DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES | |
SV2018005771A (en) | PIRIDINILTRIAZOL DERIVATIVES REPLACED WITH AMIDA AND USES OF THESE | |
BR112018076601A2 (en) | oral pharmaceutical formulation, methods for treating a patient, and use of a formulation | |
GT200900096A (en) | DOSAGE FORMS OF PALONOSETRON CHLORHYDRATE THAT HAVE IMPROVED STABILITY AND BIODISPONIBILITY | |
MA45562A (en) | STABLE LIQUID PHARMACEUTICAL PREPARATION | |
IL253237A0 (en) | Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis | |
MA46334A (en) | LIQUID PHARMACEUTICAL COMPOSITION | |
CO2020005768A2 (en) | Phytoconcentrated composition and its uses | |
UY37221A (en) | FENILTRIAZOL DERIVATIVES REPLACED WITH AMIDA AND USES OF THESE | |
CL2018003502A1 (en) | Methods to treat heterotopic ossification. | |
MX2018000546A (en) | Pharmaceutical composition containing celecoxib and tramadol. | |
CL2019000563S1 (en) | Packaging and dispensing of medicines. (divisional application 201800718) | |
GT201700007A (en) | FORMULATION IN THE FORM OF A TABLET OF 2-FLUOR-N-METHYL-4- [7- (QUINOLIN-6-YLMETIL) IMIDAZO [1,2-B] [1,2,4] TRIAZIN-2-IL] BENZAMIDA | |
PT3102187T (en) | Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets | |
CO2018002428A2 (en) | Selected amide of gamma-hydroxyiburic acid and uses thereof in the treatment of alcohol abuse | |
UY31662A1 (en) | COMPOSITIONS OF RANITIDINE TABLETS OF ORAL DISINTEGRATION AND ITS METHODS OF ELABORATION. | |
IL250418A0 (en) | Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis | |
CR20190022A (en) | Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereof | |
CO2017006985A2 (en) | Oral administration product | |
CR20170125A (en) | SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTÁN | |
IL263976A (en) | Pharmaceutical composition containing combination of memantine and melatonin | |
CL2014001581A1 (en) | Pharmaceutical combination comprising a) an antiepileptic selected from pregabalin or oxcarbazepine and b) vitamins selected from i) vitamin b12, ii) vitamin b1 and b12, with the exception of methylcobalamin and benfothiamine; pharmaceutical composition; and its use to treat or prevent moderate to severe pain; parts kit | |
CL2018002765A1 (en) | Production process of solid mesalazine formulations. | |
CL2017000026A1 (en) | Pharmaceutical dosage forms | |
PL3246058T3 (en) | Device for the preparation and administration of liquid substances, particularly antiblastic chemotherapy drugs |